Dnatrix IncCompany Details

Get alertedif Dnatrix Inc gets funded!
United States
Detailed industries:biotechnology
Company description

DNAtrix, Inc. is a biotechnology company focused on the development of oncolytic virus technology for the treatment of cancer. DNAtrix's lead product, delta24-RGD, is a next-generation adenovirus invented by company founders Dr. Juan Fueyo and Dr. Frank McCormick. delta24-RGD is designed to destroy cancer cells without harming normal tissue. It is hoped that this therapy can be added to the arsenal of surgery, radiation and chemotherapy for the treatment of a variety of tumors. The company launched its first human ...clinical trials in 2009 at the MD Anderson Cancer Center for the treatment of brain cancer. DNAtrix has been funded to date by DFJ Mercury and the Texas Emerging Technology Fund. The company is headquartered in Houston, TX. [company description from zoominfo.com] MoreLess


Funding history

DateDeal sizeInvestors 
October 15th, 2014$20,000,000Mercury Fund, Morningside Ventures, Targeted Technology FundView Deal
August 3rd, 2012$885,620-View Deal
Create alert
Want to know when Dnatrix Inc gets funded?
Key people
Imre KovesdiDirector, Executive_Officer
Francis MccormickDirector
Frank TufaroChief Executive Officer and Director, Director, Executive_Officer
Daniel WatkinsDirector, Executive_Officer
Al YungCo-Founder
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!